| Ticker Details |
Lantheus Holdings, Inc.
Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
|
| IPO Date: |
June 25, 2015 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$6.71B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.79 | 2.28%
|
| Avg Daily Range (30 D): |
$1.42 | 1.62%
|
| Avg Daily Range (90 D): |
$1.28 | 1.63%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.58M |
| Avg Daily Volume (30 D): |
.73M |
| Avg Daily Volume (90 D): |
.74M |
| Trade Size |
| Avg Trade Size (Sh.): |
64 |
| Avg Trade Size (Sh.) (30 D): |
48 |
| Avg Trade Size (Sh.) (90 D): |
47 |
| Institutional Trades |
| Total Institutional Trades: |
6,063 |
| Avg Institutional Trade: |
$3.49M |
| Avg Institutional Trade (30 D): |
$4.89M |
| Avg Institutional Trade (90 D): |
$4.99M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.04M |
| Avg Closing Trade (30 D): |
$11.81M |
| Avg Closing Trade (90 D): |
$10.8M |
| Avg Closing Volume: |
107.3K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$4.22
|
$1.83
|
$.83
|
|
Diluted EPS
|
$4.14
|
$1.8
|
$.81
|
|
Revenue
|
$1.55B
|
$377.33M
|
$406.79M
|
|
Gross Profit
|
$935.17M
|
$230.92M
|
$240.88M
|
|
Net Income / Loss
|
$279.03M
|
$118.42M
|
$54.09M
|
|
Operating Income / Loss
|
$290.09M
|
$81.33M
|
$77.18M
|
|
Cost of Revenue
|
$611M
|
$146.41M
|
$165.91M
|
|
Net Cash Flow
|
$-439.92M
|
$139.47M
|
$-22.88M
|
|
PE Ratio
|
|
|
|
|
|
|
